Page last updated: 2024-10-20

pyrazinamide and Hematologic Diseases

pyrazinamide has been researched along with Hematologic Diseases in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Hematologic Diseases: Disorders of the blood and blood forming tissues.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
VERWILGHEN, R1
REYBROUCK, G1
CALLENS, L1
COSEMANS, J1
Bozóky, G1
Ruby, E1
Góhér, I1
Tóth, J1
Mohos, A1

Other Studies

2 other studies available for pyrazinamide and Hematologic Diseases

ArticleYear
ANTITUBERCULOUS DRUGS AND SIDEROBLASTIC ANAEMIA.
    British journal of haematology, 1965, Volume: 11

    Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Anemia; Anemia, Hypochromic; Anemia, Siderobl

1965
[Hematologic abnormalities in pulmonary tuberculosiss].
    Orvosi hetilap, 1997, Apr-27, Volume: 138, Issue:17

    Topics: Anemia; Antitubercular Agents; Ethambutol; Hematologic Diseases; Humans; Leukopenia; Pancytopenia; P

1997